CEINGE is a non-profit consortium company, with entirely public capital, founded in 1983 by professor Francesco Salvatore, biochemist, Emeritus of the Federico II University, Member of the Accademia Nazionale delle Scienze. Today it counts among its members the University Hospital Federico II and the University of Naples Federico II. The main areas of competence of the Institute are: *Advanced molecular diagnostics of genetic and hereditary diseases *Extended Neonatal Screening of Hereditary Metabolic Diseases *Research in the field of molecular biology and advanced biotechnology *High-tech services supporting research in areas of expertise also accessible to SMEs, based on latest-generation genomic and post-genomic technology platforms *Higher Education in advanced biotechnologies and molecular medicine *Promotion and dissemination of scientific and technological culture to foster exchanges of knowledge between organizations linked to the research sector and for the development of biotechnologies *Technological transfer, in the sectors of interest, also through the creation of company spin-offs *Production of goods (prototypes, reagents, fine chemicals, pharmacologically and biologically active molecules, on a small scale) in the field of advanced biotechnologies